* Zepp Health Corp ZEPP.N ZEPP.K is expected to show a fall
in quarterly revenue when it reports results on November 16.
* The Hefei, Anhui-based company is expected to report a
22.9% decrease in revenue to CNY1.723 billion from CNY2.24
billion a year ago, according to the estimate from one analyst,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Zepp Health Corp is for
earnings of CNY1.57 per share. For the same quarter last year,
the company reported earnings of CNY1.85 per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Zepp Health
Corp is $13.4, about 32.3% above its last closing price
of $9.07.
This summary was machine generated November 12 at 18:01 GMT.
All figures in Chinese yuan renminbi unless otherwise stated